The global medical industry experienced a 27% decline in the number of nanomedicine-related patent applications in Q3 2023 compared with the previous quarter. The total number of nanomedicine-related grants dropped by 38% in Q3 2023, according to GlobalData’s Patent Analytics. GlobalData’s databook Medical Devices: Patents Trends Q3 2023 offers comprehensive insights into patenting trends, major players’ strategies, and geographical focus in the sector over the last three years. Buy the databook here.
Notably, the number of nanomedicine-related patent applications in the medical industry was 157 in Q3 2023, versus 216 in the prior quarter.
The top five companies accounted for 13% of patenting activity
Analysis of patenting activity by companies shows that Sanofi filed the most nanomedicine patents within the medical industry in Q3 2023. The company filed 6 nanomedicine-related patents in the quarter, compared with 10 in the previous quarter. It was followed by Korea University with 5 nanomedicine patent filings, Nanobiotix (4 filings), and LEAF Holdings Group (3 filings) in Q3 2023.
Patenting activity was driven by the US with a 62% share of total patent filings
The largest share of nanomedicine related patent filings in the medical industry in Q3 2023 was in the US with 62%, followed by China (8%) and South Korea (4%). The share represented by the US was 10% higher than the 51% share it accounted for in Q2 2023.
For further understanding of GlobalData's Medical Devices: Patents Trends Q3 2023, buy the databook here.